FCA Corp TX purchased a new position in Roche Holding AG (OTCMKTS:RHHBY - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 12,000 shares of the company's stock, valued at approximately $494,000.
A number of other hedge funds also recently modified their holdings of the stock. Fulton Bank N.A. increased its position in shares of Roche by 2.6% in the first quarter. Fulton Bank N.A. now owns 12,620 shares of the company's stock worth $518,000 after purchasing an additional 314 shares during the period. PNC Financial Services Group Inc. lifted its holdings in shares of Roche by 2.0% during the 1st quarter. PNC Financial Services Group Inc. now owns 16,234 shares of the company's stock worth $668,000 after acquiring an additional 323 shares during the period. Confluence Investment Management LLC lifted its holdings in shares of Roche by 3.6% during the 1st quarter. Confluence Investment Management LLC now owns 14,491 shares of the company's stock worth $596,000 after acquiring an additional 510 shares during the period. Accent Capital Management LLC bought a new stake in shares of Roche during the 1st quarter worth approximately $35,000. Finally, North Star Asset Management Inc. lifted its holdings in shares of Roche by 7.8% during the 1st quarter. North Star Asset Management Inc. now owns 17,305 shares of the company's stock worth $712,000 after acquiring an additional 1,255 shares during the period.
Roche Trading Up 1.3%
Shares of RHHBY stock traded up $0.51 during trading hours on Tuesday, hitting $40.12. 322,574 shares of the company's stock traded hands, compared to its average volume of 2,311,054. The stock's 50 day simple moving average is $40.06 and its 200 day simple moving average is $40.26. Roche Holding AG has a 12 month low of $34.1030 and a 12 month high of $44.31. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.48 and a quick ratio of 1.20.
Wall Street Analysts Forecast Growth
A number of analysts have recently weighed in on RHHBY shares. Hsbc Global Res downgraded shares of Roche from a "strong-buy" rating to a "hold" rating in a report on Monday, April 28th. HSBC downgraded shares of Roche from a "buy" rating to a "hold" rating in a report on Monday, April 28th. Two analysts have rated the stock with a Strong Buy rating, one has given a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of "Moderate Buy".
Check Out Our Latest Analysis on RHHBY
Roche Profile
(
Free Report)
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.
Featured Articles

Before you consider Roche, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Roche wasn't on the list.
While Roche currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.